...
首页> 外文期刊>Journal of clinical virology: The official publication of the Pan American Society for Clinical Virology >Early detection of cytomegalovirus (CMV) infection in bone marrow transplant patients by reverse transcription-PCR for CMV spliced late gene UL21.5: a two site evaluation.
【24h】

Early detection of cytomegalovirus (CMV) infection in bone marrow transplant patients by reverse transcription-PCR for CMV spliced late gene UL21.5: a two site evaluation.

机译:通过反转录PCR对CMV剪接的晚期基因UL21.5进行早期检测,以检测骨髓移植患者中巨细胞病毒(CMV)感染:两个位点的评估。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: Bone marrow transplant (BMT) patients at risk of developing cytomegalovirus (CMV) pneumonitis are identified routinely by the early detection of virus in blood. For early diagnosis of CMV infection, the RNA-based approach demonstrates advantages when compared with the current CMV antigen and DNA detection methods. OBJECTIVES: We have evaluated our previously developed reverse transcription-polymerase chain reaction (RT-PCR) to a spliced late CMV gene (SLG; J. Virol. Methods 56 (1996), 139) to monitor CMV infection in BMT patients at two clinical sites. The diagnostic value of the SLG RT-PCR was compared with the routine CMV antigen and DNA detection methods. STUDY DESIGN: Weekly blood samples from BMT patients were tested for CMV during the first 3 months post-transplant. The qualitative SLG RT-PCR, semiquantitative DNA PCR, and viral antigen tests were compared. The RNA and DNA PCR results were analysed in terms of their temporal relationship and consistency of CMV detection and compared with CMV infection diagnosed by viral antigen tests. RESULTS: Of the 101 BMT recipients studied, 25 developed CMV antigenemia and/or DNAemia resulting in symptomatic infection in two patients. All CMV PCR-positive patients were either CMV seropositive pretransplant or received marrow from seropositive donor. The highest incidence of CMV infection was seen in seropositive recipients (R+) irrespective of the donor's status. Detection of CMV infection by SLG RNA preceded CMV DNA detection by 0-2 weeks (median 1 week) and CMV antigen detection by 0-8 weeks (median 3 weeks). Once detected, the SLG RNA remained consistently positive before antiviral treatment was commenced. Both the SLG RNA and CMV DNA detection methods had the same clinical sensitivity, specificity, positive and negative predictive values of 100, 94, 80 and 100%, respectively. CONCLUSIONS: The RT-PCR for SLG RNA proved to be the earliest indicator of CMV infection in BMT patients demonstrating a sustained pattern of CMV detection during the 3 months post-transplant period. Although very similar in its diagnostic performance to CMV DNA PCR the SLG RNA RT-PCR does not require quantitation and provides an efficient and ongoing indication of active CMV infection.
机译:背景:通过早期检测血液中的病毒,可以常规鉴定有发生巨细胞病毒(CMV)肺炎风险的骨髓移植(BMT)患者。对于CMV感染的早期诊断,与当前的CMV抗原和DNA检测方法相比,基于RNA的方法具有优势。目的:我们已经评估了我们先前对剪接的晚期CMV基因的逆转录-聚合酶链反应(RT-PCR)(SLG; J. Virol。Methods 56(1996),139),以监测两种临床情况下BMT患者的CMV感染情况网站。将SLG RT-PCR的诊断价值与常规CMV抗原和DNA检测方法进行了比较。研究设计:在移植后的前3个月,对BMT患者的每周血液样本进行CMV测试。比较了定性SLG RT-PCR,半定量DNA PCR和病毒抗原检测。根据时间关系和CMV检测的一致性分析了RNA和DNA PCR结果,并与通过病毒抗原测试诊断的CMV感染进行了比较。结果:在研究的101位BMT接受者中,有25位发展为CMV抗原血症和/或DNAemia,导致两名患者出现症状感染。所有CMV PCR阳性的患者均为CMV血清阳性的移植前或接受了血清阳性供体的骨髓。血清阳性患者(R +)中CMV感染的发生率最高,而与捐赠者的状况无关。通过SLG RNA检测CMV感染先于0-2周(中位1周)检测CMV DNA,然后0-8周(中位3周)检测CMV抗原。一旦检测到,在开始抗病毒治疗之前,SLG RNA始终保持阳性。 SLG RNA和CMV DNA检测方法的临床敏感性,特异性,阳性和阴性预测值分别相同,分别为100%,94%,80%和100%。结论:SLG RNA的RT-PCR被证明是BMT患者CMV感染的最早指标,证明了在移植后3个月中CMV检测的持续模式。尽管SLG RNA RT-PCR在诊断性能上与CMV DNA PCR非常相似,但它不需要定量,可以提供有效且持续的活性CMV感染指示。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号